🕵️ CAMP4 Therapeutics Corp ($CAMP)
SEC insider & ownership activity, last 12 months · CIK 1736730 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. 5AM Partners VII, LLC added 5.3% → 6.3%; 5AM Ventures VII, L.P. added 5.3% → 6.3%. No red-flag 8-Ks in the window.
Insider flow
5 buyers, value withheld pending verification (6 lots) · 2 sellers, $2.5M (6 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Andrew J. Schwab | 0 | – | 5 | $2.5M | Aug 27, 2026 |
| Gold Kelly | 2 | $50K | 0 | – | Aug 31, 2026 |
| Richard A. Young | 1 | $27K | 0 | – | Aug 3, 2026 |
| Mandel-Brehm Josh | 1 | $11K | 0 | – | Aug 3, 2026 |
| Maricich Yuri | 1 | $11K | 0 | – | Aug 3, 2026 |
| Tardiff Daniel | 0 | – | 1 | $8K | Aug 19, 2026 |
| 5AM Partners VI, LLC | 1 | value withheld pending verification | 0 | – | Aug 3, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 12.2% | 13G | Jan 8, 2026 | filing ↗ | |
| Coastlands Capital LP | 10.0% | 13G | Dec 11, 2025 | filing ↗ | |
| Coastlands Capital Partners LP | 10.0% | 13G | Dec 11, 2025 | filing ↗ | |
| Coastlands Capital GP LLC | 10.0% | 13G | Dec 11, 2025 | filing ↗ | |
| Coastlands Capital LLC | 10.0% | 13G | Dec 11, 2025 | filing ↗ | |
| Matthew D. Perry | 10.0% | 13G | Dec 11, 2025 | filing ↗ | |
| Andrew J. Schwab | 9.9% | 13D | Aug 27, 2026 | filing ↗ | |
| Kush Parmar | 9.9% | 13D | Aug 27, 2026 | filing ↗ | |
| FMR LLC | 9.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Abigail P. Johnson | 9.5% | 13G | Feb 5, 2026 | filing ↗ | |
| VIVO Opportunity Fund Holdings, L.P. | 7.4% | 13G | Feb 13, 2026 | filing ↗ | |
| VIVO Opportunity, LLC | 7.4% | 13G | Feb 13, 2026 | filing ↗ | |
| 5AM Partners VII, LLC | 6.3% | 13D | Aug 27, 2026 | filing ↗ | |
| 5AM Ventures VII, L.P. | 6.3% | 13D | Aug 27, 2026 | filing ↗ | |
| Amir Nashat | 6.3% | 13D | Aug 13, 2026 | filing ↗ | |
| Trails EDGE Capital Partners, LP | 6.0% | 13G | Aug 10, 2026 | filing ↗ | |
| Trails EDGE Biotechnology Master Fund, LP | 6.0% | 13G | Aug 10, 2026 | filing ↗ | |
| Ortav Yehudai | 6.0% | 13G | Aug 10, 2026 | filing ↗ | |
| Balyasny Asset Management L.P. | 5.1% | 13G | May 15, 2026 | filing ↗ | |
| 5AM Ventures VI, L.P. | exited | 13D | Aug 27, 2026 | filing ↗ | |
| 5AM Partners VI, LLC | exited | 13D | Aug 27, 2026 | filing ↗ | |
| 5AM Opportunities II, L.P. | exited | 13D | Aug 27, 2026 | filing ↗ | |
| 5AM Opportunities II (GP), LLC | exited | 13D | Aug 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Daniel Tardiff | $8K | Aug 19, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 3, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 27, 2026 | filing ↗ |
| Other events (8.01) | Jul 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 18, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Mar 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 9, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 22, 2025 | filing ↗ |
| Agreement terminated (1.02) | Dec 22, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 17, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 17, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |